Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Joint-Lubricant injection ease stubborn back pain?

NCT ID NCT07775274

Symptom relief Sponsor: EPC Education s.r.o. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether adding sodium hyaluronate—a substance used to lubricate joints—to standard lidocaine injections provides better and longer-lasting pain relief for people with thoracic (mid-back) pain. Participants with persistent pain despite conservative treatment will receive either the combination or lidocaine alone. The study measures pain levels and quality of life over time to see if the addition makes a meaningful difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sodium hyaluronate injection added to standard lidocaine injection
What this could lead to
If effective, this could offer a longer-lasting, non-surgical option for people with persistent thoracic back pain.
What could go wrong
This is a small, early-stage trial, and the added benefit over standard lidocaine alone may be modest or absent. Injection-related risks like pain or infection are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Thoracic back pain as the primary complaint * Clinically significant myofascial contribution, defined by at least two of the following: * Localized tenderness * Paravertebral muscle spasm * Trigger points * Reduced skin or fascial mobility * Persistent pain despite at least 6 weeks of conservative treatment * Absence of more specific causes of pain, as determined by clinical examination and additional investigations when indicated * Age over 18 years Conditions to be excluded prior to enrollment include: * Neuropathic pain patterns, including: * Cervical or thoracic radicular pain * Intercostal neuralgia * Dorsal scapular neuralgia * Other neuralgias of thoracic region * Pleural pain patterns * Ischemic pain patterns (e.g., ischemic heart disease) * Predominantly postural pain associated with female sex and osteopenia suggestive of vertebral compression fractures Exclusion Criteria: * Lack of written informed consent * Active malignancy * Recent trauma * Age \> 70 years * Local or systemic infection * Presence of another more likely pain etiology * Severe scoliosis and/or significant chest wall deformity * History of thoracic or upper abdominal surgery * History of spinal surgery of any kind

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Back pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Back Pain Chest Pain myofascial pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Back pain Thoracic pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.